1. Home
  2. PACB vs RMNI Comparison

PACB vs RMNI Comparison

Compare PACB & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • RMNI
  • Stock Information
  • Founded
  • PACB 2000
  • RMNI 2005
  • Country
  • PACB United States
  • RMNI United States
  • Employees
  • PACB N/A
  • RMNI N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • RMNI Business Services
  • Sector
  • PACB Industrials
  • RMNI Consumer Discretionary
  • Exchange
  • PACB Nasdaq
  • RMNI Nasdaq
  • Market Cap
  • PACB 364.2M
  • RMNI 368.8M
  • IPO Year
  • PACB 2010
  • RMNI N/A
  • Fundamental
  • Price
  • PACB $1.37
  • RMNI $4.91
  • Analyst Decision
  • PACB Buy
  • RMNI Buy
  • Analyst Count
  • PACB 9
  • RMNI 2
  • Target Price
  • PACB $2.06
  • RMNI $6.00
  • AVG Volume (30 Days)
  • PACB 9.3M
  • RMNI 550.9K
  • Earning Date
  • PACB 08-06-2025
  • RMNI 07-31-2025
  • Dividend Yield
  • PACB N/A
  • RMNI N/A
  • EPS Growth
  • PACB N/A
  • RMNI N/A
  • EPS
  • PACB N/A
  • RMNI N/A
  • Revenue
  • PACB $152,357,000.00
  • RMNI $426,212,000.00
  • Revenue This Year
  • PACB $3.33
  • RMNI $1.38
  • Revenue Next Year
  • PACB $17.88
  • RMNI $3.97
  • P/E Ratio
  • PACB N/A
  • RMNI N/A
  • Revenue Growth
  • PACB N/A
  • RMNI N/A
  • 52 Week Low
  • PACB $0.85
  • RMNI $1.53
  • 52 Week High
  • PACB $2.72
  • RMNI $5.38
  • Technical
  • Relative Strength Index (RSI)
  • PACB 52.51
  • RMNI 70.76
  • Support Level
  • PACB $1.36
  • RMNI $3.87
  • Resistance Level
  • PACB $1.62
  • RMNI $5.38
  • Average True Range (ATR)
  • PACB 0.11
  • RMNI 0.28
  • MACD
  • PACB -0.01
  • RMNI 0.09
  • Stochastic Oscillator
  • PACB 41.98
  • RMNI 80.45

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

Share on Social Networks: